Neon Therapeutics (Neon Therapeutics) Insider Ownership : 6.23 % (As of May. 07, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Neon Therapeutics Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Neon Therapeutics's insider ownership is 6.23%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Neon Therapeutics's Institutional Ownership is 9.89%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Neon Therapeutics's Float Percentage Of Total Shares Outstanding is 53.01%.

Neon Therapeutics Insider Ownership Historical Data

The historical data trend for Neon Therapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neon Therapeutics Insider Ownership Chart

Neon Therapeutics Historical Data

The historical data trend for Neon Therapeutics can be seen below:

	2019-07-31	2019-08-31	2019-09-30	2019-10-31	2019-11-30	2019-12-31	2020-01-31	2020-02-29	2020-03-31	2020-04-30
Insider Ownership	4.41	4.40	4.40	4.40	4.97	4.97	6.48	6.25	6.25	6.23

Neon Therapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Neon Therapeutics (Neon Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neon Therapeutics Inc (NAS:NTGN) » Definitions » Insider Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Erie Street, Suite 110, Cambridge, MA, USA, 02139

Website

https://www.neontherapeutics.com

Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.

Executives

Cary Pfeffer	director	C/O ELEVEN BIOTHERAPEUTICS, 215 FIRST STREET, SUITE 400, CAMBRIDGE MA 02142
Jolie Siegel	officer: VP, General Counsel	C/O NEON THERAPEUTICS, INC., 40 ERIE ST., SUITE 110, CAMBRIDGE MA 02139
Robert Kamen	director	C/O JOUNCE THERAPEUTICS, INC., 1030 MASSACHUSETTS AVENUE, BOSTON MA 02210
Meryl Zausner	director	C/O NEON THERAPEUTICS, INC., 40 ERIE STREET, SUITE 110, CAMBRIDGE MA 02139
Yasir B. Al-wakeel	officer: Chief Financial Officer	MERRIMACK PHARMACEUTICALS, INC., ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE MA 02139
Eric S Lander	director	415 MAIN STREET, CAMBRIDGE MA 02142
Stephen A Sherwin	director	C/O CELL GENESYS, INC., 500 FORBES BLVD., SOUTH SAN FRANCISCO CA 94080
Robert I Tepper	director, 10 percent owner	201 BROOKLINE AVE, SUITE 1401, BOSTON MA 02215
Robert B Bazemore	director	33 HAYDEN AVE, LEXINGTON MA 02421
Richard Gaynor	officer: President of R&D	C/O NEON THERAPEUTICS, 40 ERIE STREET, SUITE 110, CAMBRIDGE MA 02139
Access Industries, Llc	other: Affiliate of 10% Owner	730 FIFTH AVENUE, NEW YORK NY 10019
Access Industries Management, Llc	other: Affiliate of 10% Owner	730 FIFTH AVENUE, NEW YORK NY 10019
Access Industries Holdings Llc	10 percent owner	C/O ACCESS INDUSTRIES MANAGEMENT, LLC., 730 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10019
Clal Biotechnology Industries Ltd.	other: See Remarks	3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR, TEL AVIV L3 67023
Len Blavatnik	other: Affiliate of 10% Owner	C/O ACCESS INDUSTRIES, 730 FIFTH AVENUE, NEW YORK NY 10019